Robert Lupinacci

3.5k citations
35 papers · 2.4k · 2 hit papers · h-index 16

Impact in

    • Antifungal resistance and susceptibility
    • Fungal Infections and Studies
    • Nail Diseases and Treatments
    • Pneumocystis jirovecii pneumonia detection and treatment
    • Pneumonia and Respiratory Infections

Papers in

    • Pneumonia and Respiratory Infections 14
    • Fungal Infections and Studies 5
    • Pneumocystis jirovecii pneumonia detection and treatment 2
    • Respiratory viral infections research 2
    • Antifungal resistance and susceptibility 13

Robert Lupinacci

34 papers receiving 2.3k citations

Robert Lupinacci's Hit Papers

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia 2004 · 647 citations
6470+8+16Years since publication250500750

Peers

Robert Lupinacci
Comparison fields: 5 of 98
  • Infectious Diseases 1.9k
  • Epidemiology 1.4k
  • Applied Microbiology and Biotechnology 79
  • Small Animals 197
  • Pharmacology 180
Replace Laura Kovanda with:
Laura Kovanda United States
Н Н Климко Russia
R.A. Barnes United Kingdom
Juergen Prattes Austria
Jack D. Sobel United States
Luis Thompson-Moya Brazil
P. K. Sharkey United States
Michele Wible United States
Matthew W. McCarthy United States
Frédéric Tissot Switzerland
Robert Lupinacci relative to Laura Kovanda United States Laura Kovanda's profile →
Citations per field
00.5×1.5×
Laura Kovanda · 1×
Citations per year

Countries citing papers authored by Robert Lupinacci

Since Specialization
Citations

This map shows the geographic impact of Robert Lupinacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lupinacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lupinacci more than expected).

Fields of papers citing papers by Robert Lupinacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lupinacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lupinacci. The network helps show where Robert Lupinacci may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Lupinacci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Lupinacci Line = papers co-authored together Robert Lupinacci links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Hit paper breakdown →
2002993
2
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
Hit paper breakdown →
2004647
3 2002210
4 2003104
5 200556
6 201239
7 200736
8 201034
9 201733
10 200729
11 200628
12 202328
13 200226
14 201121
15 202315
16 202315
17 202313
18 201112
19 202411
20 202211

About Robert Lupinacci

Robert Lupinacci is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (14 papers), Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (5 papers), Phosphodiesterase function and regulation (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Respiratory viral infections research (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Infectious Diseases (1.9k citations), Epidemiology (1.4k citations), Applied Microbiology and Biotechnology (79 citations), Small Animals (197 citations) and Pharmacology (180 citations). Robert Lupinacci has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Carole A. Sable, Nicholas A. Kartsonis, Arnaldo Lopes Colombo, John R. Perfect, Robert F. Betts, Luis Thompson-Moya, Coleman Rotstein, Michael Bourque, Hedy Teppler and Johan Maertens. Their work appears in journals such as Vaccine, Open Forum Infectious Diseases, New England Journal of Medicine, European Journal of Clinical Microbiology & Infectious Diseases and American Journal of Health-System Pharmacy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact